StockNow
Log in
U.S. Markets

France to expand access to weight-loss drugs for obesity patients, AFP reports citing sources

News detail

France will soon reimburse 65% of the cost of weight-loss drugs Wegovy (NOVOB DC) and Mounjaro (LLY) for severely obese patients, two informed sources told AFP. Health Minister to announce the scheme before its publication in the official journal of new legislation.

2 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYGeopolitics

Pakistani sources say Pakistan PM Sharif and Army Chief Munir will visit Saudi Arabia tomorrow, Al Hadath reports

U.S. Economy

US ADP Employment Change (Jul) 44K vs. Exp. 70K (Prev. 98K)